Comparison of Vesikari and Clark scales regarding the definition of severe rotavirus gastroenteritis in children

References

• Grimwood K, Lambert SB. Rotavirus vaccines: opportunities and challenges. Hum Vaccin 2009;5:57–69.
   PubMed Web of Science ®Google Scholar
• Parashar UD, Gibson CJ, Bresse JS, Glass R. Rotavirus and severe childhood diarrhea. Emerg Infect Dis 2006;12:304–6.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Rotavirus vaccines. WHO position paper. Wkly Epidemiol Rec 2013;88:49–64.
   PubMedGoogle Scholar
• Karsten C, Baumgarte S, Friedrich AW, von Eiff C, Becker K, Wosniok W, et al. Incidence and risk factors for community-acquired acute gastroenteritis in north-west Germany in 2004. Eur J Clin Microbiol Infect Dis 2009;28:935–43.
   Google Scholar
• Iwata S, Nakata S, Ukae S, Koizumi Y, Morita Y, Kuroki H, et al. Efficacy and safety of pentavalent rotavirus vaccine in Japan: a randomized, double-blind, placebo-controlled, multicenter trial. Hum Vaccin Immunother 2013;9:1626–33.
   PubMed Web of Science ®Google Scholar
• Parashar UD, Hummelman EG, Bresee JS, Miller MA, Glass RI. Global illness and deaths caused by rotavirus disease in children. Emerg Infect Dis 2003;9:565–72.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Meeting of the immunization Strategic Advisory Group of Experts, April 2009 Conclusions and recommendations. Wkly Epidemiol Rec 2009;84: 220–36. Available from http://www.who.int/wer/2009/wer8423.pdf. Accessed 11 Nov 2014.
   Google Scholar
• Bhandari N, Rongsen-Chandola T, Bavdekar A, John J, Antony K, Taneja S, et al. India Rotavirus Vaccine Group. Efficacy of a monovalent human–bovine (116E) rotavirus vaccine in Indian infants: a randomised, double-blind, placebo-controlled trial. Lancet 2014;383:2136–43.
   PubMed Web of Science ®Google Scholar
• Zade JK, Kulkarni PS, Desai SA, Sabale RN, Naik SP, Dhere RM. Bovine rotavirus pentavalent vaccine development in India. Vaccine 2014;32(Suppl 1):124–8.
   Google Scholar
• Armah GE, Sow SO, Breiman RF, Dallas MJ, Tapia MD, Feikin DR, et al. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial. Lancet 2010;376:606–14.
   PubMed Web of Science ®Google Scholar
• Linhares AC, Velazquez FR, Perez-Schael I, Saez-Llorens X, Abate H, Espinoza F, et al. Human Rotavirus Vaccine Study Group. Efficacy and safety of an oral live attenuated human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in Latin American infants: a randomised, double-blind, placebo-controlled phase III study. Lancet 2008;371:1181–9.
   Google Scholar
• Ruuska T, Vesikari T. Rotavirus disease in Finnish children: use of numerical scores for clinical severity of diarrhoeal episodes. Scand J Infect Dis 1990;22:259–67.
   PubMed Web of Science ®Google Scholar
• Clark HF, Borian FE, Bell LM, Modesto K, Gouvea V, Plotkin SA. Protective effect of WC3 vaccine against rotavirus diarrhea in infants during a predominantly serotype 1 rotavirus season. J Infect Dis 1988;158:570–87.
   PubMed Web of Science ®Google Scholar
• Ruiz-Palacios GM, Perez-Schael I, Velazquez FR, Abate H, Breuer T, Clemens SC, et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med 2006;354:11–22.
   PubMed Web of Science ®Google Scholar
• Vesikari T, Matson DO, Dennehy P, Van Damme P, Santosham M, Rodriguez Z, et al. Safety and efficacy of a pentavalent human–bovine (WC3) reassortant rotavirus vaccine. N Engl J Med 2006;354:23–33.
   PubMed Web of Science ®Google Scholar
• Zaman K, Anh DD, Victor JC, Shin S, Yunus M, Dallas MJ, et al. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial. Lancet 2010;376:615–23.
   PubMed Web of Science ®Google Scholar
• Sow SO, Tapia M, Haidara FC, Ciarlet M, Diallo F, Kodio M, et al. Efficacy of the oral pentavalent rotavirus vaccine in Mali. Vaccine 2012;30(Suppl 1):71–8.
   Google Scholar
• Givon-Lavi N, Greenberg D, Dagan R. Comparison between two severity scoring scales commonly used in the evaluation of rotavirus gastroenteritis in children. Vaccine 2008;26:5798–801.
   PubMed Web of Science ®Google Scholar
• Lewis K, Dallas M, Victora J, Ciarlet M, T. Mast C, Ji M, et al. Comparison of two clinical severity scoring systems in two multi-center, developing country rotavirus vaccine trials in Africa and Asia. Vaccine 2012;30(Suppl 1):159–66.
   Google Scholar
• Sowmyanarayanan TV, Ramani S, Sarkar R, Arumugam R, Warier JP, Moses PD, et al. Severity of rotavirus gastroenteritis in Indian children requiring hospitalization. Vaccine 2012; 30(Suppl 1):167–72.
   Google Scholar
• World Health Organization. The treatment of diarrhoea: a manual for physicians and other senior health workers. 4th rev. Geneva:WHO; 2005. Available from http://whqlibdoc.who.int/publications/2005/9241593180.pdf. Accessed 11 Nov 2014.
   Google Scholar
• Viera AJ, Garrett JM. Understanding interobserver agreement: the kappa statistic. Fam Med 2005;37:360–3.
   PubMed Web of Science ®Google Scholar
• Madhi S.A, Cunliffe NA, Steele D, Witte D, Kirsten M, Louw C, et al. Effect of human rotavirus vaccine on severe diarrhea in African infants. N Engl J Med 2010; 362:289–98.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Generic protocol for monitoring impact of rotavirus vaccination on gastroenteritis disease burden and viral strains. Geneva: WHO; 2008. Available from http://whqlibdoc.who.int/hq/2008/WHO_ IVB_ 08.16_eng.pdf. Accessed 11 Nov 2014.
   Google Scholar
• Lewis K. PATH Vesikari clinical severity scoring system manual. 2 May 2011. Available from http://www.path.org/publications/files/VAD_vesikari_scoring_manual.pdf. Accessed 11 Nov 2014.
   Google Scholar